In a groundbreaking medical achievement, China has become the first country to use artificial intelligence (AI) to guide a robot during a heart operation. The procedure took place on September 5 at the People's Liberation Army General Hospital, where an AI-controlled ultrasound robot performed a minimally invasive catheter-based closure on a 48-year-old patient with a congenital heart defect. This type of surgery involves inserting a thin, flexible tube (called a catheter) into a blood vessel and guiding it to the heart to place a device that seals a defect. Real-time imaging was used to help direct the catheter accurately. The robot performed the task without continuous human control, scanning the heart tissue and identifying the exact location of the defect. The AI acted as both the "eyes" and "navigation system" for the robot, allowing it to move independently and place the occlusion device with extreme precision—within a fraction of a millimeter. According to hospital officials, this marks a major step forward in medical technology, with the potential to improve the accuracy of surgeries and change the way cardiovascular care is delivered. Currently, procedures like catheter-based closure require highly specialized skills that doctors spend many years to develop. By using AI-guided systems, the risk of human error could be reduced, and access to advanced treatments could be expanded globally. This technology could also be valuable in other areas of healthcare, such as quickly assessing injuries in emergency situations or providing rapid diagnostic imaging in battlefield conditions. This development highlights the growing role of AI in medicine, offering new possibilities for complex procedures that were once limited to only the most experienced surgeons. As the technology advances, it may lead to more efficient, safer, and more widely available medical treatments in the future.